FDA Accepts NDA for ZYOGREEN by PROVEPHARM SAS
The FDA has accepted the New Drug Application for ZYOGREEN, an injection containing Indocyanine Green.
Asset / Drug
Drug and asset intelligence for ZYOGREEN with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.